- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07636733
The Effect of Vitamin D Supplementation on the Anti-inflammatory Response in Periodontal Diseases
The Effect of Vitamin D Levels and Supplementation on Anti-inflammatory Response in Periodontal Disease: a Randomized Controlled Clinical Trial
A review of the literature revealed that while there are studies investigating the relationship between vitamin D and periodontal disease, there are no studies investigating the anti-inflammatory effect of vitamin D on periodontal disease. Investigators hypothesized that the increased incidence of periodontal disease in individuals with vitamin D deficiency might be due not only to pro-inflammatory effects but also to impaired bone metabolism and a decrease in the anti- inflammatory mechanism. Investigators aimed to determine this by comparing serum and DOS levels of 1,25-dihydroxyvitamin D (1,25(OH)2D), 25-hydroxyvitamin D (25(OH)D3), Receptor activator nuclear kappa B ligand (RANKL), osteoprotegerin (OPG), Tumor Necrosis Factor Related Apoptosis induced Ligand (TRAIL), Developmental endothelial locus (Del)-1, Lipoxin, Resolvin, interleukin (IL)-10, and transforming growth factor-β (TGF-β).
The study will include 120 individuals who are systemically healthy based on clinical and radiographic examinations and diagnosed with Stage I-II periodontitis, Stage III-IV periodontitis, chronic gingivitis, and periodontally healthy. Periodontal clinical parameters (Probing pocket depth (PPD), Clinical attachment level (CAL), Bleeding on probing (BOP), Plaque index (PI), Gingival index (GI)) will be recorded three times: before treatment, and 6 and 12 weeks after treatment. Gingival crevicular fluid (GCF) and serum samples will be collected from participants at baseline and 12 weeks later for biochemical analysis.
Studieoversigt
Status
Betingelser
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Hatice Yemenoglu
- Telefonnummer: +905052977517
- E-mail: htcymnglu@hotmail.com
Studiesteder
-
-
-
Rize, Tyrkiet (Türkiye), 53020
- Rekruttering
- Recep Tayyip Erdogan University
-
Kontakt:
- Hatice Yemenoglu
- Telefonnummer: +904642220000
- E-mail: htcymnglu@hotmail.com
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- Study groups will be formed according to the 2017 Periodontal Disease Classification. Accordingly:
- Periodontally healthy; absence of bleeding on probing, erythema, edema, patient symptoms, attachment, and bone loss
- Gingivitis; patients with an average gingival index ≥0.5 according to Löe and Silness
- Stage I-II periodontitis; patients with CAL 1-2 or 3-4 mm and a maximum PPD ≤5 mm, showing radiographic horizontal bone loss up to the coronal third of the root (15%-33%), but without tooth loss due to periodontitis
- Stage III-IV periodontitis; Stage 3 and 4 patients with ≥15 teeth in their mouth, with CAL ≥5 and PPD ≥6 in at least 6 areas, and radiographic bone loss extending to the middle or apical third of the root.
Exclusion Criteria:
- Individuals who have undergone periodontal treatment in the last 6 months, have systemic diseases (such as diabetes, parathyroid and thyroid-related endocrine diseases) that may affect periodontal status, patients with chronic liver disease, hypoparathyroidism and renal failure, those who have been using medications that may affect periodontal response (aspirin, non-steroidal anti-inflammatory drugs or steroids) for a long time, those who are using additional vitamin D or calcium supplements in the pre-study phase, those who are pregnant or breastfeeding, and those with hypercalcemia and malabsorption syndrome will not be included in the study.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Diagnostisk
- Tildeling: Randomiseret
- Interventionel model: Faktoriel opgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Group 1: Stage I-II periodontitis group with vitamin D deficiency
|
Participants will receive non-surgical periodontal treatment
Participants with vitamin D deficiency will receive supplemental vitamin D as recommended by their doctor
Participants will receive oral hygiene education
|
|
Eksperimentel: Group 2: Stage I-II periodontitis group with vitamin D deficiency
|
Participants will receive non-surgical periodontal treatment
Participants will receive oral hygiene education
|
|
Eksperimentel: Group 3: Stage III-IV periodontitis with vitamin D deficiency
|
Participants will receive non-surgical periodontal treatment
Participants with vitamin D deficiency will receive supplemental vitamin D as recommended by their doctor
Participants will receive oral hygiene education
|
|
Eksperimentel: Group 4: Stage III-IV periodontitis with vitamin D deficiency
|
Participants will receive non-surgical periodontal treatment
Participants will receive oral hygiene education
|
|
Eksperimentel: Group 5: Chronic gingivitis with vitamin D deficiency
|
Participants will receive non-surgical periodontal treatment
Participants with vitamin D deficiency will receive supplemental vitamin D as recommended by their doctor
Participants will receive oral hygiene education
|
|
Eksperimentel: Group 6: Chronic gingivitis with vitamin D deficiency
|
Participants will receive non-surgical periodontal treatment
Participants will receive oral hygiene education
|
|
Eksperimentel: Group 7: Periodontally healthy group with sufficient vitamin D levels
|
Participants will receive oral hygiene education
|
|
Eksperimentel: Group 8: Periodontally healthy group with vitamin D deficiency
|
Participants will receive oral hygiene education
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Probing pocket depth (PPD)
Tidsramme: These parameters will be recorded three times: before treatment, and 6 and 12 weeks after treatment
|
These parameters will be recorded three times: before treatment, and 6 and 12 weeks after treatment
|
|
Clinical attachment level (CAL)
Tidsramme: These parameters will be recorded three times: before treatment, and 6 and 12 weeks after treatment
|
These parameters will be recorded three times: before treatment, and 6 and 12 weeks after treatment
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Collection of gingival crevicular fluid and serum samples
Tidsramme: These parameters were to be recorded 2 times: before treatment and 12 weeks after treatment
|
These parameters were to be recorded 2 times: before treatment and 12 weeks after treatment
|
Samarbejdspartnere og efterforskere
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- KAD-FR-42
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Periodontale sygdomme
-
Riga Stradins UniversityUniversity of TurkuRekrutteringParadentose | Periodontale sygdomme | Parodontalt knogletab | Periodontal sygdom | Periodontal regenerering | Periodontal helbredelse | Periodontal granulationsvæv | Vertikale parodontale knogledefekterLetland
-
University of Roma La SapienzaAktiv, ikke rekrutterendePeriodontal sygdom | Periodontal sygdom, AVDC trin 3 | Periodontal sygdom fase 2Italien
-
Uskudar UniversityRekrutteringRygning | Paradentose | Periodontal sygdom | Periodontal sundhed | InflammasomerTyrkiet (Türkiye)
-
Beni-Suef UniversityRekrutteringPeriodontal sundhedEgypten
-
Cairo UniversityRekrutteringIntrabony periodontal defektEgypten
-
Cairo UniversityIkke rekrutterer endnuIntrabony periodontal defektEgypten
-
SVS Institute of Dental SciencesRekrutteringIntrabony periodontal defektIndien
-
Krishnadevaraya College of Dental Sciences & HospitalUkendtIntrabony periodontal defektIndien
-
Universitat Internacional de CatalunyaAfsluttetIntrabony periodontal defekt
-
Panineeya Mahavidyalaya Institute of Dental Sciences...AfsluttetIntrabony periodontal defekt
Kliniske forsøg med Non-surgical periodontal treatment
-
Hartford HospitalAstellas Pharma IncAfsluttetProlaps af bækkenorganerForenede Stater
-
Assistance Publique - Hôpitaux de ParisAfsluttetIdiopatisk Membranøs NefropatiFrankrig